These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Naturally occurring clavines: antagonism/partial agonism at 5-HT2A receptors and antagonism at alpha 1-adrenoceptors in blood vessels. Pertz H Planta Med; 1996 Oct; 62(5):387-92. PubMed ID: 8923801 [TBL] [Abstract][Full Text] [Related]
6. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro. Germonpré PR; Joos GF; Pauwels RA Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563 [TBL] [Abstract][Full Text] [Related]
7. Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist. Rinaldi-Carmona M; Congy C; Santucci V; Simiand J; Gautret B; Neliat G; Labeeuw B; Le Fur G; Soubrie P; Breliere JC J Pharmacol Exp Ther; 1992 Aug; 262(2):759-68. PubMed ID: 1501121 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery. Hamel E; Robert JP; Young AR; MacKenzie ET J Pharmacol Exp Ther; 1989 Jun; 249(3):879-89. PubMed ID: 2732950 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the contractile 5-hydroxytryptamine receptor in the renal artery of the normotensive rat. Watts SW; Thompson JM J Pharmacol Exp Ther; 2004 Apr; 309(1):165-72. PubMed ID: 14724222 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor. Wainscott DB; Cohen ML; Schenck KW; Audia JE; Nissen JS; Baez M; Kursar JD; Lucaites VL; Nelson DL Mol Pharmacol; 1993 Mar; 43(3):419-26. PubMed ID: 8450835 [TBL] [Abstract][Full Text] [Related]
12. Differential inhibition of 5-hydroxytryptamine (5-HT) mediated contraction of rat thoracic aortae by phentolamine and tolazoline: correlation with inhibition of 5-HT binding and calcium ion. Curro FA; Greenberg S Methods Find Exp Clin Pharmacol; 1983; 5(2):107-20. PubMed ID: 6876942 [TBL] [Abstract][Full Text] [Related]
13. Cycloalkanecarboxylic esters derived from lysergol, dihydrolysergol-I, and elymoclavine as partial agonists and antagonists at rat 5-HT2A receptors: pharmacological evidence that the indolo[4,3-fg]quinoline system of the ergolines is responsible for high 5-HT2A receptor affinity. Pertz HH; Milhahn H; Eich E J Med Chem; 1999 Feb; 42(4):659-68. PubMed ID: 10052973 [TBL] [Abstract][Full Text] [Related]
14. Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat. Lucki I; Nobler MS; Frazer A J Pharmacol Exp Ther; 1984 Jan; 228(1):133-9. PubMed ID: 6694097 [TBL] [Abstract][Full Text] [Related]
15. [3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H] ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor. Branchek T; Adham N; Macchi M; Kao HT; Hartig PR Mol Pharmacol; 1990 Nov; 38(5):604-9. PubMed ID: 2233697 [TBL] [Abstract][Full Text] [Related]
16. Relationship between receptors mediating serotonin (5-HT) contractions in the canine basilar artery to 5-HT1, 5-HT2 and rat stomach fundus 5-HT receptors. Cohen ML; Colbert WE J Pharmacol Exp Ther; 1986 Jun; 237(3):713-8. PubMed ID: 3712277 [TBL] [Abstract][Full Text] [Related]
17. Recombinant saphenous vein 5-HT1B receptors of the rabbit: comparative pharmacology with human 5-HT1B receptors. Wurch T; Palmier C; Colpaert FC; Pauwels PJ Br J Pharmacol; 1997 Jan; 120(1):153-9. PubMed ID: 9117091 [TBL] [Abstract][Full Text] [Related]
18. The subtype of serotonin (5-HT) receptors in the rat pulmonary artery. Uma S; Tuncer M; Kayaalp SO Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):248-55. PubMed ID: 3675084 [TBL] [Abstract][Full Text] [Related]
19. Species differences in the pharmacology of the 5-hydroxytryptamine2 receptor: structurally specific differentiation by ergolines and tryptamines. Nelson DL; Lucaites VL; Audia JE; Nissen JS; Wainscott DB J Pharmacol Exp Ther; 1993 Jun; 265(3):1272-9. PubMed ID: 8510008 [TBL] [Abstract][Full Text] [Related]
20. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors. Lyon RA; Davis KH; Titeler M Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]